EGFR and non-small cell lung carcinoma: Another study evaluating the molecular profile of 87 NSCLC samples by qPCR or NGS found that 18.4% of patients had EGFR activating mutations (12 cases with the exon 19 deletions and 4 patients carrying the p.L858R) [28].